Literature DB >> 15708909

A potential pitfall in the use of the Disease Activity Score (DAS28) as the main response criterion in treatment guidelines for patients with rheumatoid arthritis.

P V Gardiner, A L Bell, A J Taggart, G Wright, F Kee, A Smyth, R McKane, J Lee, M E Rooney, E Whitehead.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15708909      PMCID： PMC1755401          DOI： 10.1136/ard.2004.025015

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  5 in total

1.  Ultrasound7 versus ultrasound12 in monitoring the response to infliximab in patients with rheumatoid arthritis.

Authors:  Xiaomei Leng; Weiguo Xiao; Zhonghui Xu; Xiaochun Zhu; Yi Liu; Dongbao Zhao; Huji Xu; Guoqiang Chen; Wei Yu; Jing Lu; Jiakai Wang; Xiaoru Xia; Yongji Li; Yi Zhao; Honghu Tang; Yeqing Shi; Jun Bao; Ling Chen; Li Lin; Ling Zhou; Hongwei Zhang; Yan Zhao
Journal:  Clin Rheumatol       Date:  2016-01-19       Impact factor: 2.980

2.  Clinical disease activity and acute phase reactant levels are discordant among patients with active rheumatoid arthritis: acute phase reactant levels contribute separately to predicting outcome at one year.

Authors:  Jonathan Kay; Olga Morgacheva; Susan P Messing; Joel M Kremer; Jeffrey D Greenberg; George W Reed; Ellen M Gravallese; Daniel E Furst
Journal:  Arthritis Res Ther       Date:  2014-02-03       Impact factor: 5.156

3.  The efficacy of the traditional Chinese medicine Jia Wei Niu Bang Zi granule combined with methotrexate in treating active rheumatoid arthritis: A multicenter, randomized, double-blinded controlled clinical trial.

Authors:  Yi-Ru Wang; Li Liu; Xiao-Yun Wang; Qiong Wang; Min Yao; Xue-Jun Cui; Jian-Chun Mao; Jian Liu; Xiao-Hua Gu; Yong-Li Chen; Xiang Yu; Qi Shi; Qian-Qian Liang; Yong-Jun Wang
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

4.  Blood monocyte chemotactic protein-1 (MCP-1) and adapted disease activity Score28-MCP-1: favorable indicators for rheumatoid arthritis activity.

Authors:  Lieh-bang Liou; Wen-pin Tsai; Chee J Chang; Wan-ju Chao; Meng-hsin Chen
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240

5.  The efficacy of the traditional Chinese medicine Juanbi pill combined with methotrexate in active rheumatoid arthritis: study protocol for a randomized controlled trial.

Authors:  Qiong Wang; Yi-Ru Wang; Qing-Yun Jia; Li Liu; Chong-Qing Xu; Xiao-Yun Wang; Min Yao; Xue-Jun Cui; Qi Shi; Yong-Jun Wang; Qian-Qian Liang
Journal:  Trials       Date:  2018-03-20       Impact factor: 2.279
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.